Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias

Details for Australian Patent Application No. 2002300055 (hide)

Owner Axonyx National Institute of Health

Inventors Brossi, Arnold; Hausman, Marvin; Soncrant, Timothy T; Yu, Qian-Sheng; Greig, Nigel H

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002300055

Parent 749088

Filing date 8 July 2002

Wipo publication date 12 December 2002

International Classifications

A61K 031/047

Event Publications

12 December 2002 Application Open to Public Inspection

  Published as AU-A-2002300055

20 November 2003 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300056-Fluid delivery system

2002300054-Syringe with retractable needle and safety lock